Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression

-

 

Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression







By Lori Solomon, HealthDay Reporter

MONDAY, Dec. 23, 2024 -- A high omega-3, low omega-6 diet with fish oil supplementation for one year results in a significant reduction of a marker of prostate cancer progression among men enrolled in active surveillance (AS), according to a study published online on Dec. 13 in the Journal of Clinical Oncology.

William J. Aronson, M.D., from the University of California, Los Angeles, and colleagues examined whether a high omega-3, low omega-6 fatty acid diet with fish oil capsules (D + FO) decreases proliferation (Ki-67) in prostate biopsies in men with prostate cancer over one year of AS. The analysis included 100 men with grade 1 or 2 prostate cancer who elected AS.

The researchers found that the Ki-67 index decreased in the D + FO group by approximately 15 percent from baseline to one year (1.34 to 1.14 percent at one year) and increased in the control group by approximately 24 percent from baseline to one year (1.23 to 1.52 percent at one year), yielding a statistically significant difference in the change of the Ki-67 index between the groups. For the secondary outcomes, grade group, tumor length, Decipher genomic score, and prostate-specific antigen did not significantly differ between the two groups. In the D + FO group, four patients withdrew from the trial because of adverse events related to the FO.

"These findings support future phase III trials incorporating this intervention in men on AS," the authors write.

Two authors disclosed ties to the pharmaceutical industry.


Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Comments

Post a Comment

Popular posts from this blog

B12 MAY HELP PREVENT ALZHEIMER'S DISEASE.

-
Image
  B12 MAY HELP PREVENT ALZHEIMER'S DISEASE. Worms don't wiggle when they have Alzheimer's disease. Yet something helped worms with the disease hold onto their wiggle in Professor Jessica Tanis's lab at the University of Delaware. In solving the mystery, Tanis and her team have yielded new clues into the potential impact of diet on Alzheimer's, the dreaded degenerative brain disease afflicting more than 6 million Americans. A few years ago, Tanis and her team began investigating factors affecting the onset and progression of Alzheimer's disease. They were doing genetic research with  C. elegans , a tiny soil-dwelling worm subject of numerous studies. Expression of amyloid-beta, a toxic protein implicated in Alzheimer's disease, paralyzes worms within 36 hours of reaching adulthood. While the worms in one petri dish in Tanis's lab were rendered completely immobile, the worms of the same age in the adjacent petri dish still had their wiggle, documented as ...
Read more

EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH

-
Image
  EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH          July 2023 was the hottest month, with cities like Phoenix experiencing record-breaking heat waves for weeks. A new study finds that ongoing extreme heat can worsen cognitive decline among vulnerable groups -- particularly Black older adults and those living in poor neighborhoods. "Our research finds that cumulative exposure to extreme heat can undermine cognitive health, but it does so unequally across the population," said Eunyoung Choi, a postdoctoral associate at the NYU School of Global Public Health and the first author of the study, published in the  Journal of Epidemiology and Community Health . Extreme heat is the leading cause of weather-related deaths in the U.S., claiming more lives each year than hurricanes, tornadoes, and lightning combined. Young children and older adults are particularly vulnerable to heat-related illnesses such as heat exhaustion and heat stroke. Recent stud...
Read more

Diabetes drugs may reduce the risk of Alzheimer’s.

-
Image
    Diabetes drugs may reduce the risk of Alzheimer’s. The study finds people taking the drugs have fewer biomarkers, slower cognitive decline. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease compared to people with type 2 diabetes who are not taking the drugs and those without diabetes. The new study, published in the August 11, 2021, online issue of  Neurology , the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise. "People with diabetes have been shown to ...
Read more